Retail Healthcare Sector

Aspira Women's Health

Market Cap: US$2.3m

Aspira Women's Health Inc., together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States.

Diagnamed Holdings

Market Cap: CA$3.3m

Engages in the development and commercialization of AI healthcare solutions.

Venus Concept

Market Cap: US$2.3m

A medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

Helius Medical Technologies

Market Cap: US$2.3m

A neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma.

PHSC

Market Cap: UK£1.7m

Through its subsidiaries, provides health, safety, hygiene, and environmental consultancy services and security solutions to the public and private sectors in the United Kingdom.

Me Today

Market Cap: NZ$3.8m

Through its subsidiaries, engages in the production, sale, and marketing of health and wellbeing products in New Zealand, the United States, and Europe.

Cambium Bio

Market Cap: AU$3.5m

A clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications.

Neural Therapeutics

Market Cap: CA$3.1m

A drug discovery company, focuses on plant-based active substances.

Vectus Biosystems

Market Cap: AU$3.5m

Engages in the medical research and development activities in Australia.

NewGenIvf Group

Market Cap: US$2.2m

An investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan.

Omega Therapeutics

Market Cap: US$2.2m

Operates as a clinical-stage biotechnology company.

Silo Pharma

Market Cap: US$2.2m

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.

TALi Digital

Market Cap: AU$3.3m

A digital health company, delivers diagnostic and therapeutic solutions to enhance attention cognitive function in Australia.

VG Life Sciences

Market Cap: US$2.1m

A biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation.

Strainsforpains

Market Cap: US$2.1m

Operates as a medical marijuana data recommendation system.

Universe Pharmaceuticals

Market Cap: US$2.1m

Through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China.

Revitalist Lifestyle and Wellness

Market Cap: CA$2.8m

Operates medical clinics.

CannaPharmaRX

Market Cap: US$2.0m

Engages in acquisition, development, and operation of cannabis cultivation facilities in Canada.

Entero Therapeutics

Market Cap: US$2.0m

A clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases.

Aptevo Therapeutics

Market Cap: US$2.0m

A clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States.

Agentix

Market Cap: US$2.0m

A clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States.

Craftport Cannabis

Market Cap: CA$2.7m

Engages in the production and sale of recreational cannabis under the Craftport Cannabis brand in Canada.

Radient Technologies

Market Cap: CA$2.7m

Processes, manufactures, sells, and distributes cannabis materials in Canada and internationally.

JRSIS Health Care

Market Cap: US$1.9m

Develops and produces medical technology and equipment in the People’s Republic of China.

Aditxt

Market Cap: US$1.9m

A commercial-stage company, discovers and develops products in the areas of immune health, precision health, population health, women’s health, and neurologic health.

TNF Pharmaceuticals

Market Cap: US$1.9m

A clinical-stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms.

DXS International

Market Cap: UK£1.4m

A healthcare IT company, develops and distributes clinical decision support solutions to general practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa.

Vaxxinity

Market Cap: US$1.9m

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

ZyVersa Therapeutics

Market Cap: US$1.9m

Operates as a clinical stage biopharmaceutical company that develops and commercializes products for the treatment of renal and inflammatory diseases.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.

Medical Marijuana

Market Cap: US$1.9m

An investment holding company, operates in the cannabinoid-based nutraceutical industry.

Allied

Market Cap: US$1.9m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

Pangenomic Health

Market Cap: CA$2.6m

Operates as a precision health company.

Standard Dental Labs

Market Cap: US$1.8m

A dental laboratory company, manufactures dental products in Florida.

Careteq

Market Cap: AU$2.8m

A medication management services company for health, aged, and home care sectors worldwide.

ENDRA Life Sciences

Market Cap: US$1.8m

Develops technologies to improve the capabilities of clinical diagnostic ultrasound.